Relay Therapeutics Inc
NASDAQ:RLAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
US |
|
En Japan Inc
TSE:4849
|
JP |
|
Lam Research Corp
NASDAQ:LRCX
|
US |
|
Grupo Aeroportuario del Centro Norte SAB de CV
BMV:OMAB
|
MX |
|
Micron Technology Inc
NASDAQ:MU
|
US |
|
Note AB (publ)
STO:NOTE
|
SE |
|
C
|
Cal-Comp Electronics Thailand PCL
SET:CCET
|
TH |
|
Kuaishou Technology
HKEX:1024
|
CN |
|
HSBC Holdings PLC
LSE:HSBA
|
UK |
|
Marathon Petroleum Corp
NYSE:MPC
|
US |
|
L
|
Life Science REIT PLC
LSE:LABS
|
UK |
|
S
|
Siam Global House PCL
SET:GLOBAL
|
TH |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
Carnival Corp
NYSE:CCL
|
US |
|
AC Immune SA
NASDAQ:ACIU
|
CH |
|
Woodward Inc
NASDAQ:WWD
|
US |
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
Renasant Corp
NYSE:RNST
|
US |
|
KLX Energy Services Holdings Inc
NASDAQ:KLXE
|
US |
|
W
|
Willis Towers Watson PLC
NASDAQ:WTW
|
UK |
|
Odfjell Drilling Ltd
OSE:ODL
|
BM |
|
Valiant Holding AG
SIX:VATN
|
CH |
|
Evercore Inc
NYSE:EVR
|
US |
Wall St Price Targets
RLAY Price Targets Summary
Relay Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
RLAY is 21.42 USD with a low forecast of 18.18 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RLAY's stock price target?
Price Target
21.42
USD
According to Wall Street analysts, the average 1-year price target for
RLAY is 21.42 USD with a low forecast of 18.18 USD and a high forecast of 26.25 USD.
What is the Revenue forecast for Relay Therapeutics Inc?
Projected CAGR
74%
The compound annual growth rate for Revenue over the next 8 years is 74%.